The list of partners who work with us continues to grow.
MII combines strong local market knowledge with an execution mindset. They supported our go-to-market work, introduced relevant stakeholders, and helped us structure collaborations with clinics and partners in a way that truly moves the business forward. This was particularly valuable for our automatic speech recognition (ASR) product serving healthcare and social care.
MII demonstrated outstanding professionalism and a truly client-focused approach. Their team delivered high-quality work and practical support throughout the project, helping us move forward efficiently.
Together with MII in 2024, we created an Acceleration Program for biotech start up’s and conducted first edition in 2025. Working with MII was smooth, structured, and genuinely partner-oriented. They combined strategic thinking with practical execution, enabling us to engage startups more effectively and build a collaboration model that works in real life. We found their life science expertise very usefull, especially due to a unique combination with business models awareness leading to smooth comercialization of deep tech solutions. We had a written agreement at the beginning but later on forgot about it and based our cooperation entirely on trust.
I consider the support of companies such as MII at the early stage of product development and even its conception to be the most valuable thing in our medtech ecosystem. Start-ups avoid costs and are afraid of consulting companies. I share these views. However, a service such as MII can save us a lot of costs that we would otherwise face. People who know the market well and contribute to the new technology ecosystem want to share their knowledge. This is less costly than the time and mistakes made by founders trying to do everything themselves, which ultimately ends up with them hiring an expert.
Our collaboration with MII significantly supported our entry into the Polish biotech ecosystem. Their team connected us with relevant startups, investors, academic institutions, and other key stakeholders, enabling us to establish meaningful and lasting partnerships in Poland.
“Healthtech start-ups in practice:
Lessons from pilots in medical facilities”.
Our experience and expertise allows us to drive improvements in the health sector while supporting MedTech startups and pharmaceutical projects. We focus on the Health Value methodology to increase value for patients and the healthcare system.
Through our collaborations, we aim to create both scientific and business value, enabling our partners to actively pursue and close sales.
